Ascentage Pharma Group International Balance Sheet

Balance Sheet Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 0.20B0.14B0.12B
Cash & Current Investments 0.20B0.14B0.12B
Receivables - Net 0.02B0.01B
Receivables - Other 0.00B0.00B
Receivables 0.02B0.01B
Raw Materials 0.00B0.00B
Work In Process 0.00B0.00B
Finished Goods 0.00B0.00B
Inventory 0.00B0.00B
Prepaid Assets 0.01B0.02B
Current Assets 0.19B0.20B
Non-Current Assets
Property, Plant & Equipment (Net) 0.13B0.12B
Long-Term Investments 0.00B0.00B
Goodwill 0.00B0.00B
Intangibles 0.01B0.01B0.01B
Goodwill & Intangibles 0.01B0.02B0.01B
Long-Term Deferred Tax 0.93B0.01B0.01B
Other Non-Current Assets 0.00B0.00B0.01B
Non-Current Assets 0.16B0.16B
Liabilities
Total Liabilities -0.06B0.34B0.32B
Current Liabilities
Accounts Payables 0.01B0.01B
Accumulated Expenses -17.67B-5.20B0.00B
Other Accumulated Expenses 0.21B0.04B
Current Leases 0.00B0.00B
Current Deferred Revenue 0.25B0.01B
Total Current Liabilities 0.13B0.16B
Non-Current Liabilities
Non-Current Deffered Revenue 0.04B0.03B
Non-Current Deferred Tax Liability 0.00B0.01B0.00B
Operating Leases 0.00B0.00B0.00B
Other Non-Current Liabilities 0.00B0.00B
Total Non-Current Liabilities 0.21B0.16B
Shareholder's Equity
Common Equity 0.06B0.01B0.04B
Shareholder's Equity 0.06B0.01B0.04B
Treasury Shares -0.02B0.00B
Retained Earnings -0.76B-0.79B